OPTN required SARS‐CoV‐2 lower respiratory testing for lung donors: Striking the balance-Reference-Cited by-同舟云学术

OPTN required SARS‐CoV‐2 lower respiratory testing for lung donors: Striking the balance

Published:2023-03-02 Issue:3 Volume:25 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Booker Sarah E.¹,Jett Courtney¹^ORCID,Fox Cole¹,Anesi Judith A.²^ORCID,Berry Gerald J.³,Dunn Kelly E.⁴,Fisher Cynthia E.⁵^ORCID,Goldman Jason D.⁵⁶^ORCID,Ho Chak‐Sum⁷⁸,Kittleson Michelle⁹,Lee Dong Heun¹⁰,Levine Deborah J.¹¹,Marboe Charles C.¹²,Marklin Gary¹³,Martinez Carlos¹,Razonable Raymund R.¹⁴^ORCID,Sellers Marty T.¹⁵,Taimur Sarah¹⁶^ORCID,Te Helen S.¹⁷,Trindade Anil J.¹⁸^ORCID,Wood R. Patrick¹⁹,Woolley Ann E.²⁰,Zaffiri Lorenzo²¹,Klassen David K.¹^ORCID,Michaels Marian G.²²,Pouch Stephanie M.²³,Danziger‐Isakov Lara²⁴^ORCID,La Hoz Ricardo M.²⁵^ORCID

Affiliation:

1. United Network for Organ Sharing Richmond Virginia USA

2. Division of Infectious Diseases Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Pathology Stanford University School of Medicine Stanford California USA

4. Tufts Medical Center Boston Massachusetts USA

5. Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA

6. Organ Transplant and Liver Center Swedish Medical Center Seattle Washington USA

7. Gift of Hope Organ and Tissue Donor Network Itasca Illinois USA

8. College of Human Medicine Michigan State University East Lansing Michigan USA

9. Department of Cardiology Smidt Heart Institute Cedars‐Sinai Medical Center Los Angeles California USA

10. Division of Infectious Diseases University of California San Francisco San Francisco California USA

11. Department of Medicine University of Texas Health Science Center San Antonio Texas USA

12. Department of Pathology and Cell Biology Columbia University New York New York USA

13. Mid‐America Transplant St Louis Missouri USA

14. Division of Public Health Infectious Diseases and Occupational Medicine and the William J von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic Rochester Minnesota USA

15. DCI Donor Services, Inc. Nashville Tennessee USA

16. Icahn School of Medicine at Mount Sinai New York New York USA

17. Center for Liver Diseases University of Chicago Medicine Chicago Illinois USA

18. Division of Allergy Pulmonary and Critical Care Medicine Vanderbilt University Medical Center Nashville Tennessee USA

19. LifeGift Organ Donation Center Houston Texas USA

20. Division of Infectious Diseases Brigham and Women's Hospital Boston Massachusetts USA

21. Cedars‐Sinai Medical Center Los Angeles California USA

22. Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

23. Emory University School of Medicine Atlanta Georgia USA

24. Cincinnati Children's Hospital Medical Center and University of Cincinnati Cincinnati Ohio USA

25. Division of Infectious Disease and Geographic Medicine University of Texas Southwestern Medical Center Dallas Texas USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.14048

Reference5 articles.

1. Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Through Solid Organ Transplantation and Outcomes of Coronavirus Disease 2019 Among Recent Transplant Recipients

2. A call to routinely test lower respiratory tract samples for SARS‐CoV‐2 in lung donors

3. Donor to recipient transmission of SARS‐CoV‐2 by lung transplantation despite negative donor upper respiratory tract testing

4. BookerS.Lower respiratory SARS‐CoV‐2 testing for lung donors: 1 year post‐implementation monitoring report. OPTN;2022.

5. Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid;Journal of Virological Methods;2024-01

2. Minimizing the Risk of Donor-Derived Events and Maximizing Organ Utilization Through Education and Policy Development;Infectious Disease Clinics of North America;2023-09